Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 16 studies | 55% ± 19% | |
glutamatergic neuron | 12 studies | 60% ± 24% | |
oligodendrocyte precursor cell | 9 studies | 28% ± 9% | |
GABAergic neuron | 8 studies | 39% ± 17% | |
amacrine cell | 6 studies | 31% ± 15% | |
interneuron | 6 studies | 34% ± 15% | |
neuron | 5 studies | 37% ± 13% | |
fibroblast | 5 studies | 25% ± 9% | |
endothelial cell | 3 studies | 45% ± 21% | |
GABAergic interneuron | 3 studies | 30% ± 13% | |
GABAergic amacrine cell | 3 studies | 61% ± 20% | |
ependymal cell | 3 studies | 41% ± 20% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 36% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 95% | 2150.57 | 2517 / 2642 | 98% | 11.66 | 694 / 705 |
prostate | 81% | 937.16 | 199 / 245 | 30% | 0.71 | 153 / 502 |
bladder | 95% | 1105.38 | 20 / 21 | 10% | 0.28 | 49 / 504 |
blood vessel | 99% | 2042.90 | 1315 / 1335 | 0% | 0 | 0 / 0 |
lung | 88% | 678.34 | 509 / 578 | 10% | 0.30 | 110 / 1155 |
esophagus | 57% | 682.54 | 826 / 1445 | 5% | 0.20 | 9 / 183 |
uterus | 44% | 229.78 | 75 / 170 | 16% | 1.00 | 74 / 459 |
stomach | 43% | 1068.16 | 154 / 359 | 8% | 0.22 | 23 / 286 |
ovary | 33% | 197.94 | 60 / 180 | 5% | 0.14 | 22 / 430 |
adipose | 34% | 184.74 | 408 / 1204 | 0% | 0 | 0 / 0 |
skin | 19% | 88.93 | 338 / 1809 | 5% | 0.27 | 22 / 472 |
breast | 12% | 49.48 | 53 / 459 | 10% | 0.32 | 108 / 1118 |
kidney | 9% | 29.28 | 8 / 89 | 11% | 0.34 | 98 / 901 |
tonsil | 0% | 0 | 0 / 0 | 16% | 0.39 | 7 / 45 |
intestine | 6% | 37.21 | 55 / 966 | 2% | 0.05 | 8 / 527 |
heart | 6% | 22.60 | 53 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 6% | 0.27 | 13 / 230 |
pancreas | 0% | 0.81 | 1 / 328 | 5% | 0.07 | 9 / 178 |
thymus | 2% | 7.70 | 12 / 653 | 3% | 0.08 | 16 / 605 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.77 | 1 / 29 |
liver | 0% | 0 | 0 / 226 | 3% | 0.08 | 12 / 406 |
spleen | 1% | 4.46 | 3 / 241 | 0% | 0 | 0 / 0 |
muscle | 1% | 3.19 | 6 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0048667 | Biological process | cell morphogenesis involved in neuron differentiation |
GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
GO_0016358 | Biological process | dendrite development |
GO_0098609 | Biological process | cell-cell adhesion |
GO_1904936 | Biological process | interneuron migration |
GO_2000171 | Biological process | negative regulation of dendrite development |
GO_0010842 | Biological process | retina layer formation |
GO_0005886 | Cellular component | plasma membrane |
GO_0030425 | Cellular component | dendrite |
GO_0005509 | Molecular function | calcium ion binding |
Gene name | FAT3 |
Protein name | Prostate cancer FAT3 Protocadherin Fat 3 (hFat3) (Cadherin family member 15) (FAT tumor suppressor homolog 3) FAT atypical cadherin 3 (HCG21202, isoform CRA_a) Protocadherin Fat 3 |
Synonyms | hCG_21202 KIAA1989 CDHF15 |
Description | FUNCTION: May play a role in the interactions between neurites derived from specific subsets of neurons during development. . |
Accessions | Q6S4P6 ENST00000409404.6 [Q8TDW7-3] ENST00000525166.6 [Q8TDW7-1] Q8TDW7 G5EA25 ENST00000525166 E9PQ73 ENST00000533797.1 |